Tapewire

Nasdaq · USD

ACAD

ACADIA PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
3913
SEC CIK
0001070494
Parsed reports
339

Last 12 months

Inside the activity.

0 purchase rows · 24 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202500
Jan 202600
Feb 202601
Mar 202609
Apr 202602
May 202603
Jun 202601
Jul 202602
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 05, 2026 Filed Apr 7, 2026 23:57 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 5,276 Not disclosed Not disclosed
Disclosure

SEC source: 0001899977-26-000005 · form4-04072026_110411.xml · nonDerivative · entry 1

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 05, 2026 Filed Apr 7, 2026 23:55 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
Exercise / conversionRestricted Stock Units · Derivative 2,010 $0.00 $0.00
Disclosure

SEC source: 0001816160-26-000005 · form4-04072026_110435.xml · derivative · entry 3

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,010 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning April 5, 2023.

F4 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning April 5, 2023.

Read SEC document
April 05, 2026 Filed Apr 7, 2026 23:55 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
Exercise / conversionCommon Stock 2,010 Not disclosed Not disclosed
Disclosure

SEC source: 0001816160-26-000005 · form4-04072026_110435.xml · nonDerivative · entry 1

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 26, 2026 Filed Mar 27, 2026 00:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
SaleCommon Stock 37 $21.72 $803.54
Disclosure

SEC source: 0001899977-26-000003 · form4-03262026_080301.xml · nonDerivative · entry 5

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,269

F2 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
March 26, 2026 Filed Mar 27, 2026 00:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
SaleCommon Stock 3,171 $21.65 $68,652.15
Disclosure

SEC source: 0001899977-26-000003 · form4-03262026_080301.xml · nonDerivative · entry 4

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,306

F2 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
March 26, 2026 Filed Mar 27, 2026 00:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
SaleCommon Stock 12 $21.73 $260.70
Disclosure

SEC source: 0001816160-26-000003 · form4-03262026_080304.xml · nonDerivative · entry 5

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,885

F2 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
March 26, 2026 Filed Mar 27, 2026 00:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
SaleCommon Stock 1,097 $21.65 $23,750.05
Disclosure

SEC source: 0001816160-26-000003 · form4-03262026_080304.xml · nonDerivative · entry 4

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,897

F2 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
March 25, 2026 Filed Mar 27, 2026 00:00 UTC
Owen Adams CatherineDirector · Chief Executive Officer
SaleCommon Stock 11,641 $21.47 $249,932.27
Disclosure

SEC source: 0001816838-26-000003 · form4-03262026_080310.xml · nonDerivative · entry 2

Owen Adams Catherine · CIK 0001816838 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,803

F3 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
March 25, 2026 Filed Mar 27, 2026 00:00 UTC
Thompson Elizabeth H.Z.EVP, Head of Research & Dev
SaleCommon Stock 3,435 $21.47 $73,749.45
Disclosure

SEC source: 0001861477-26-000003 · form4-03262026_080306.xml · nonDerivative · entry 2

Thompson Elizabeth H.Z. · CIK 0001861477 · EVP, Head of Research & Dev

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,280

F2 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
March 25, 2026 Filed Mar 27, 2026 00:00 UTC
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC
SaleCommon Stock 3,844 $21.47 $82,530.68
Disclosure

SEC source: 0001568249-26-000005 · form4-03262026_080308.xml · nonDerivative · entry 2

Rhodes Jennifer J · CIK 0001568249 · EVP, CHIEF LEGAL OFFICER, SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,280

F2 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
March 25, 2026 Filed Mar 27, 2026 00:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Units · Derivative 6,178 $0.00 $0.00
Disclosure

SEC source: 0001899977-26-000003 · form4-03262026_080301.xml · derivative · entry 7

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,358

Underlying: Common Stock · 6,178 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 25, 2025.

F4 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 25, 2025.

Read SEC document
March 25, 2026 Filed Mar 27, 2026 00:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 6,178 Not disclosed Not disclosed
Disclosure

SEC source: 0001899977-26-000003 · form4-03262026_080301.xml · nonDerivative · entry 3

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,477

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 25, 2026 Filed Mar 27, 2026 00:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
SaleCommon Stock 4,177 $21.47 $89,680.19
Disclosure

SEC source: 0001899977-26-000003 · form4-03262026_080301.xml · nonDerivative · entry 2

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,299

F2 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
March 25, 2026 Filed Mar 27, 2026 00:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
Exercise / conversionRestricted Stock Units · Derivative 2,142 $0.00 $0.00
Disclosure

SEC source: 0001816160-26-000003 · form4-03262026_080304.xml · derivative · entry 7

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,284

Underlying: Common Stock · 2,142 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 25, 2025.

F4 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 25, 2025.

Read SEC document
March 25, 2026 Filed Mar 27, 2026 00:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
Exercise / conversionCommon Stock 2,142 Not disclosed Not disclosed
Disclosure

SEC source: 0001816160-26-000003 · form4-03262026_080304.xml · nonDerivative · entry 3

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,994

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 25, 2026 Filed Mar 27, 2026 00:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
SaleCommon Stock 833 $21.47 $17,884.51
Disclosure

SEC source: 0001816160-26-000003 · form4-03262026_080304.xml · nonDerivative · entry 2

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,852

F2 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Owen Adams CatherineDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 23,509 $0.00 $0.00
Disclosure

SEC source: 0001816838-26-000003 · form4-03262026_080310.xml · derivative · entry 3

Owen Adams Catherine · CIK 0001816838 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,530

Underlying: Common Stock · 23,509 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

F4 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Owen Adams CatherineDirector · Chief Executive Officer
Exercise / conversionCommon Stock 23,509 $0.00 $0.00
Disclosure

SEC source: 0001816838-26-000003 · form4-03262026_080310.xml · nonDerivative · entry 1

Owen Adams Catherine · CIK 0001816838 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,444

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 2,935 shares of the Issuer's common stock acquired by the reporting person on May 15, 2025 pursuant to an employee stock purchase plan.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Thompson Elizabeth H.Z.EVP, Head of Research & Dev
Exercise / conversionRestricted Stock Units · Derivative 6,715 $0.00 $0.00
Disclosure

SEC source: 0001861477-26-000003 · form4-03262026_080306.xml · derivative · entry 3

Thompson Elizabeth H.Z. · CIK 0001861477 · EVP, Head of Research & Dev

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,146

Underlying: Common Stock · 6,715 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Thompson Elizabeth H.Z.EVP, Head of Research & Dev
Exercise / conversionCommon Stock 6,715 Not disclosed Not disclosed
Disclosure

SEC source: 0001861477-26-000003 · form4-03262026_080306.xml · nonDerivative · entry 1

Thompson Elizabeth H.Z. · CIK 0001861477 · EVP, Head of Research & Dev

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,715

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC
Exercise / conversionRestricted Stock Units · Derivative 7,515 $0.00 $0.00
Disclosure

SEC source: 0001568249-26-000005 · form4-03262026_080308.xml · derivative · entry 3

Rhodes Jennifer J · CIK 0001568249 · EVP, CHIEF LEGAL OFFICER, SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,547

Underlying: Common Stock · 7,515 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC
Exercise / conversionCommon Stock 7,515 $0.00 $0.00
Disclosure

SEC source: 0001568249-26-000005 · form4-03262026_080308.xml · nonDerivative · entry 1

Rhodes Jennifer J · CIK 0001568249 · EVP, CHIEF LEGAL OFFICER, SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Units · Derivative 8,138 $0.00 $0.00
Disclosure

SEC source: 0001899977-26-000003 · form4-03262026_080301.xml · derivative · entry 6

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,414

Underlying: Common Stock · 8,138 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 8,138 Not disclosed Not disclosed
Disclosure

SEC source: 0001899977-26-000003 · form4-03262026_080301.xml · nonDerivative · entry 1

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
Exercise / conversionRestricted Stock Units · Derivative 1,627 $0.00 $0.00
Disclosure

SEC source: 0001816160-26-000003 · form4-03262026_080304.xml · derivative · entry 6

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,883

Underlying: Common Stock · 1,627 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 24, 2026.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
Exercise / conversionCommon Stock 1,627 Not disclosed Not disclosed
Disclosure

SEC source: 0001816160-26-000003 · form4-03262026_080304.xml · nonDerivative · entry 1

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,685

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
GrantRestricted Stock Units · Derivative 6,332 $0.00 $0.00
Disclosure

SEC source: 0001816160-26-000002 · form4-03102026_060314.xml · derivative · entry 2

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,332

Underlying: Common Stock · 6,332 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
GrantStock Option (Right to Buy) · Derivative 21,766 $0.00 Strike: $22.16 $0.00
Disclosure

SEC source: 0001816160-26-000002 · form4-03102026_060314.xml · derivative · entry 1

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,766

Underlying: Common Stock · 21,766 shares

Expires 2036-03-05

F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC
GrantRestricted Stock Units · Derivative 26,382 $0.00 $0.00
Disclosure

SEC source: 0001568249-26-000004 · form4-03102026_060312.xml · derivative · entry 2

Rhodes Jennifer J · CIK 0001568249 · EVP, CHIEF LEGAL OFFICER, SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,382

Underlying: Common Stock · 26,382 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC
GrantStock Option (Right to Buy) · Derivative 90,691 $0.00 Strike: $22.16 $0.00
Disclosure

SEC source: 0001568249-26-000004 · form4-03102026_060312.xml · derivative · entry 1

Rhodes Jennifer J · CIK 0001568249 · EVP, CHIEF LEGAL OFFICER, SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,691

Underlying: Common Stock · 90,691 shares

Expires 2036-03-05

F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
GrantRestricted Stock Units · Derivative 26,382 $0.00 $0.00
Disclosure

SEC source: 0001899977-26-000002 · form4-03102026_060310.xml · derivative · entry 2

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,382

Underlying: Common Stock · 26,382 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
GrantStock Option (Right to Buy) · Derivative 90,691 $0.00 Strike: $22.16 $0.00
Disclosure

SEC source: 0001899977-26-000002 · form4-03102026_060310.xml · derivative · entry 1

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,691

Underlying: Common Stock · 90,691 shares

Expires 2036-03-05

F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Garner ThomasEVP, Chief Commercial Officer
GrantRestricted Stock Units · Derivative 28,493 $0.00 $0.00
Disclosure

SEC source: 0001996325-26-000002 · form4-03102026_060309.xml · derivative · entry 2

Garner Thomas · CIK 0001996325 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,493

Underlying: Common Stock · 28,493 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Garner ThomasEVP, Chief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 97,947 $0.00 Strike: $22.16 $0.00
Disclosure

SEC source: 0001996325-26-000002 · form4-03102026_060309.xml · derivative · entry 1

Garner Thomas · CIK 0001996325 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,947

Underlying: Common Stock · 97,947 shares

Expires 2036-03-05

F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Thompson Elizabeth H.Z.EVP, Head of Research & Dev
GrantRestricted Stock Units · Derivative 29,548 $0.00 $0.00
Disclosure

SEC source: 0001861477-26-000002 · form4-03102026_060307.xml · derivative · entry 2

Thompson Elizabeth H.Z. · CIK 0001861477 · EVP, Head of Research & Dev

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,548

Underlying: Common Stock · 29,548 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Thompson Elizabeth H.Z.EVP, Head of Research & Dev
GrantStock Option (Right to Buy) · Derivative 101,574 $0.00 Strike: $22.16 $0.00
Disclosure

SEC source: 0001861477-26-000002 · form4-03102026_060307.xml · derivative · entry 1

Thompson Elizabeth H.Z. · CIK 0001861477 · EVP, Head of Research & Dev

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,574

Underlying: Common Stock · 101,574 shares

Expires 2036-03-05

F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Owen Adams CatherineDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 76,509 $0.00 $0.00
Disclosure

SEC source: 0001816838-26-000002 · form4-03102026_060303.xml · derivative · entry 2

Owen Adams Catherine · CIK 0001816838 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,509

Underlying: Common Stock · 76,509 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 6, 2027.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:00 UTC
Owen Adams CatherineDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 263,005 $0.00 Strike: $22.16 $0.00
Disclosure

SEC source: 0001816838-26-000002 · form4-03102026_060303.xml · derivative · entry 1

Owen Adams Catherine · CIK 0001816838 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 263,005

Underlying: Common Stock · 263,005 shares

Expires 2036-03-05

F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

Read SEC document
March 03, 2026 Filed Mar 20, 2026 22:01 UTC GrantRestricted Stock Units · Derivative 2,010 $0.00 $0.00
Disclosure

SEC source: 0001604689-26-000006 · form4-03202026_100313.xml · derivative · entry 4

Poole Jonathan · CIK 0001604689 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,010

Underlying: Common Stock · 2,010 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F5 · derivative.exercise_date: The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.

F5 · derivative.expiration_date: The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.

Read SEC document
March 03, 2026 Filed Mar 20, 2026 22:01 UTC GrantRestricted Stock Units · Derivative 4,218 $0.00 $0.00
Disclosure

SEC source: 0001604689-26-000006 · form4-03202026_100313.xml · derivative · entry 3

Poole Jonathan · CIK 0001604689 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,218

Underlying: Common Stock · 4,218 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units will vest in equal annual installments over three years following the date of grant such that the restricted stock units will be fully vested on the third anniversary of the date of grant.

F4 · derivative.expiration_date: The restricted stock units will vest in equal annual installments over three years following the date of grant such that the restricted stock units will be fully vested on the third anniversary of the date of grant.

Read SEC document
March 03, 2026 Filed Mar 20, 2026 22:01 UTC GrantDirector Stock Options (Right to Buy) · Derivative 3,565 $0.00 Strike: $22.50 $0.00
Disclosure

SEC source: 0001604689-26-000006 · form4-03202026_100313.xml · derivative · entry 2

Poole Jonathan · CIK 0001604689 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,565

Underlying: Common Stock · 3,565 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The shares subject to the stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders.

Read SEC document
March 03, 2026 Filed Mar 20, 2026 22:01 UTC GrantDirector Stock Options (Right to Buy) · Derivative 7,482 $0.00 Strike: $22.50 $0.00
Disclosure

SEC source: 0001604689-26-000006 · form4-03202026_100313.xml · derivative · entry 1

Poole Jonathan · CIK 0001604689 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,482

Underlying: Common Stock · 7,482 shares

Expires 2036-03-02

F1 · derivative.exercise_date: The shares subject to the stock option will vest in equal annual installments over three years following the date of grant such that the stock option will be fully vested on the third anniversary of the date of grant.

Read SEC document
February 09, 2026 Filed Feb 10, 2026 23:00 UTC
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC
SaleCommon Stock 6,950 $23.38 $162,491.00
Disclosure

SEC source: 0001568249-26-000002 · form4-02102026_060201.xml · nonDerivative · entry 2

Rhodes Jennifer J · CIK 0001568249 · EVP, CHIEF LEGAL OFFICER, SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,609

F3 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.38 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 23:00 UTC
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC
Exercise / conversionRestricted Stock Units · Derivative 12,944 $0.00 $0.00
Disclosure

SEC source: 0001568249-26-000002 · form4-02102026_060201.xml · derivative · entry 3

Rhodes Jennifer J · CIK 0001568249 · EVP, CHIEF LEGAL OFFICER, SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,945

Underlying: Common Stock · 12,944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: 50% of the restricted stock units vested on February 6, 2026 and 25% vest on each of February 6, 2027 and February 6, 2028.

F5 · derivative.expiration_date: 50% of the restricted stock units vested on February 6, 2026 and 25% vest on each of February 6, 2027 and February 6, 2028.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 23:00 UTC
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC
Exercise / conversionCommon Stock 12,944 $0.00 $0.00
Disclosure

SEC source: 0001568249-26-000002 · form4-02102026_060201.xml · nonDerivative · entry 1

Rhodes Jennifer J · CIK 0001568249 · EVP, CHIEF LEGAL OFFICER, SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,559

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 595 shares of the Issuer's common stock acquired by the reporting person on May 15, 2025 pursuant to an employee stock purchase plan.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 23:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
SaleCommon Stock 10,262 $23.69 $243,113.96
Disclosure

SEC source: 0001899977-25-000006 · form4-11192025_061103.xml · nonDerivative · entry 3

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,338

F3 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.69 to $23.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 23:00 UTC
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
SaleCommon Stock 4,084 $23.69 $96,753.64
Disclosure

SEC source: 0001816160-25-000004 · form4-11192025_061101.xml · nonDerivative · entry 3

Kihara James · CIK 0001816160 · PRINCIPAL ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,058

F3 · kind: The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.69 to $23.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 23:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Units · Derivative 9,913 $0.00 $0.00
Disclosure

SEC source: 0001899977-25-000006 · form4-11192025_061103.xml · derivative · entry 5

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,913 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period.

F6 · derivative.expiration_date: The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 23:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Units · Derivative 9,913 $0.00 $0.00
Disclosure

SEC source: 0001899977-25-000006 · form4-11192025_061103.xml · derivative · entry 4

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,913 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.

F5 · derivative.expiration_date: The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 23:00 UTC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 9,913 Not disclosed Not disclosed
Disclosure

SEC source: 0001899977-25-000006 · form4-11192025_061103.xml · nonDerivative · entry 2

Schneyer Mark C. · CIK 0001899977 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.